OpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant Bacteria
OpGen, Inc. today announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for anti…
OpGen, Inc. today announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for anti…
IGeneX is excited to announce the availability of their newly-developed, advanced testing methods …
The US Food and Drug Administration (FDA) has approved a point-of-care influenza (flu) A & B 2…
First Light Biosciences, a developer of breakthrough automated diagnostic products for rapid, sens…
A team of scientists at Columbia University Mailman School of Public Health has developed a diagno…
Use of the US Food and Drug Administration–approved Accelerate Pheno blood culture detection syste…
CERTUS, innovators in food safety technologies, announces that its CERTUS System for accurate and …
The use of an oral rapid HIV test facilitated by a certified health educator (CHE) can significant…
GenePOC Inc., member of the Debiopharm Group, is proud to announce the approval by Health Canada a…
PathSensors’ cutting-edge CANARY based assays for the detection of Ralstonia spp. and Phytophtho…
Bruker Corporation announced that is has completed the acquisition of an 80% majority interest in …
When you get sick, you want the right treatment fast. But certain infectious microbes are experts …
The UK startup company Oxford Nanopore Technologies is speeding the discovery of pathogens with it…
Karius, a life sciences company transforming infectious disease diagnostics with genomics, along w…
The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,072,309 to Dr. D…